The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
Combination therapy for Buruli ulcer (BU) is suboptimal. Here, Liu et al. show that the candidate drug TB47 has potent bactericidal activity against Mycobacterium ulcerans in vitro and in a mouse model, which underscores its potential for shortening the course of BU and treating other mycobacterial...
Guardado en:
Autores principales: | Yang Liu, Yamin Gao, Jianxiong Liu, Yaoju Tan, Zhiyong Liu, Chiranjibi Chhotaray, Huofeng Jiang, Zhili Lu, Gift Chiwala, Shuai Wang, Gaelle Makafe, Md Mahmudul Islam, H. M. Adnan Hameed, Xingshan Cai, Changwei Wang, Xinjie Li, Shouyong Tan, Tianyu Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3eb099eeaf12439699ea5255f9ccaab6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding the transmission of Mycobacterium ulcerans: A step towards controlling Buruli ulcer.
por: Anthony J Muleta, et al.
Publicado: (2021) -
A protocol for culturing environmental strains of the Buruli ulcer agent, Mycobacterium ulcerans
por: Dezemon Zingue, et al.
Publicado: (2018) -
Targeting the Mycobacterium ulcerans cytochrome bc 1 :aa 3 for the treatment of Buruli ulcer
por: Nicole Scherr, et al.
Publicado: (2018) -
Amoebae as potential environmental hosts for Mycobacterium ulcerans and other mycobacteria, but doubtful actors in Buruli ulcer epidemiology.
por: Sophie Gryseels, et al.
Publicado: (2012) -
Chronic wounds in Sierra Leone: Searching for Buruli ulcer, a NTD caused by Mycobacterium ulcerans, at Masanga Hospital.
por: Helen R Please, et al.
Publicado: (2021)